Je. Coury et al., A NOVEL ASSAY FOR DRUG-DNA BINDING MODE, AFFINITY, AND EXCLUSION NUMBER - SCANNING FORCE MICROSCOPY, Proceedings of the National Academy of Sciences of the United Statesof America, 93(22), 1996, pp. 12283-12286
Determining the mode-of-binding of a DNA ligand is not always straight
forward. Here, we establish a scanning force microscopic assay for mod
e-of binding that is (i) direct: lengths of individual DNA-ligand comp
lexes are directly measured; (ii) rapid: there are no requirements for
staining or elaborate sample preparation; and (iii) unambiguous: an o
bserved increase in DNA length upon addition of a ligand is definitive
evidence for an intercalative mode-of-binding, Mode-of-binding, bindi
ng affinity, and site-exclusion number are readily determined from sca
nning force microscopy measurements of the changes in length of indivi
dual drug-DNA complexes as a function of drug concentration. With this
assay, we resolve the ambiguity surrounding the mode of binding of 2,
5-bis(4-amidinophenyl)furan (APF) to DNA and show that it binds to DNA
by nonintercalative modes. APF is a member of an important class of a
romatic dicationic drugs that show significant activity in the treatme
nt of Pneumocystis carinii pneumonia, an opportunistic infection that
is the leading cause of death in AIDS patients.